Delivery Order SPE2DE22D0008-SPE2D625F9X35

Award Date 3/26/25
Potential Completion Date 3/31/25
Potential Value $1.1K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $17,441.00. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of ALBACLONE Anti-P1 medical products, which are likely critical blood banking supplies supporting diagnostic testing, blood typing, and...
This federal contract award, valued at $2,370.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The award is a Delivery Order contract for the supply of ALBACLONE Anti-A products. This contract is not set aside for any specific type of small business. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and has a history of providing specialized medical...
This contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order for $14,457.00 with Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is for the delivery of ALBACLONE Anti-A products and has a completion date of September 5, 2024. This contract is not designated as a set-aside. Alba...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $10,500.00, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is being awarded by the Defense Logistics Agency (DLA) Medical Supply Chain and is for the supply of ALBACLONE Anti-C (Big C) reagents. The...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The contract, valued at $4,582.00, is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the provision of ALBACYTE Antibody ID Panels, which are specialized blood banking products used for diagnostic testing, blood typing, and transfusion...
This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the provision of ALBACLONE ANTI-A medical supplies. The contract has a ceiling value of $1,123.00 and a period of performance through April 4, 2024. It is a firm fixed price contract, and there was no set-aside designation used. Alba Bioscience, Inc. is a leading provider of specialized in vitro diagnostics and blood bank reagents, and this...
This federal contract award was made by the Medical Supply Chain, a defense agency, to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The $1,560.00 firm fixed price delivery order is for ALBACLONE anti-LEA products, with a completion date of May 19, 2025. Alba Bioscience, Inc. holds several significant federal Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D625F9X35
    Delivery Order

This is a federal contract award to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain, is for the delivery of ALBACLONE Anti-A blood banking products with a ceiling value of $1,118.00. The contract is a Firm Fixed Price Delivery Order and has an ultimate completion date of March 31, 2025. This contract is not designated as a set-aside and is part of a larger Indefinite Delivery Vehicle (IDV) relationship between Alba Bioscience and the Department of Veterans Affairs (VA), including two Blanket Purchase Agreements (BPAs) for red blood cell reagents and blood bank reagents, respectively.

Generated 6/29/25, 1:07 AM